Antioxidant treatment does not prevent chronic hypoxia-induced respiratory muscle impairment in developing rats

Adv Exp Med Biol. 2010:669:263-6. doi: 10.1007/978-1-4419-5692-7_53.

Abstract

Litters of rats were exposed to normobaric normoxia or hypobaric hypoxia (P(B)= 450 mmHg) for 7 days at 3 different time points during early development (postnatal day (P)1, P6 & P11). A separate litter exposed to hypoxia at P11 was treated with the antioxidant Tempol (100 mg/kg) given by oral administration daily starting at P8. At P19, sternohyoid and diaphragm muscles were removed and isolated muscle bundles were mounted isometrically in physiological salt solution at 30 degrees C in vitro. Fatigue was assessed in response to repeated stimulation (40 Hz) every 2 s for 5 min. Fatigue index was measured. Chronic hypoxia decreased sternohyoid, but not diaphragm, muscle endurance. Tempol treatment did not prevent hypoxia-induced muscle plasticity, suggesting that reactive oxygen species are not implicated in hypoxia-induced muscle dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cyclic N-Oxides / pharmacology
  • Diaphragm / drug effects
  • Diaphragm / physiopathology
  • Female
  • Free Radical Scavengers / pharmacology*
  • Hypoxia / physiopathology*
  • Male
  • Muscle Contraction / drug effects
  • Muscle Fatigue / drug effects
  • Rats
  • Rats, Wistar
  • Respiratory Muscles / drug effects*
  • Respiratory Muscles / physiopathology*
  • Spin Labels
  • Time Factors

Substances

  • Cyclic N-Oxides
  • Free Radical Scavengers
  • Spin Labels
  • tempol